Breast Cancer
News
FDA approves Tecentriq plus Abraxane in breast cancer
The immunotherapy regimen received accelerated approval for the treatment of PD-L1-positive triple-negative breast cancer in adults.
From the Journals
Anthracycline-free regimen OK in HER2-negative early breast cancer
There were no differences in disease-free or overall survival or distant recurrence-free interval between regimens with or without epirubicin.
Conference Coverage
Therapy ups breast cancer survivors’ cardiac risks
WASHINGTON – Anthracycline-based chemotherapy, anti-HER2 agents, and radiation all increase the risk for subsequent heart disease in breast cancer...
News
FDA approves third trastuzumab biosimilar
The drug is approved for treatment of HER2-overexpressing breast cancer and HER2-overexpressing metastatic gastric or gastroesophageal junction...
Latest News
Soy didn’t up all-cause mortality in breast cancer survivors
The ongoing study tracks with previous work showing no risk from dietary soy.
Daily News Podcast
Daily News Special: SABCS
The latest clinical medicine news from the 2018 annual San Antonio Breast Cancer Symposium.
Clinical Review
Managing menopausal vasomotor and genitourinary symptoms after breast cancer
Two cases on selecting safe and useful treatments for survivors of breast cancer experiencing distressing quality-of-life...
From the Journals
Actionable mutations more likely in women with both breast and uterine cancer
At least one actionable mutation was seen in 14% of women with breast and uterine cancer, compared with 9.3% of women with breast cancer only, in...
Conference Coverage
Young women opt for mastectomy even when neoadjuvant chemo works well
SAN ANTONIO – Although neoadjuvant chemotherapy doubled the proportion of women eligible for breast-conserving surgery, about 40% chose mastectomy...
Conference Coverage
Older breast cancer patients given adjuvant chemo live longer
SAN ANTONIO – Overall survival is better in breast cancer patients aged 65 years and older who receive adjuvant chemotherapy, although patients...
Conference Coverage
QOL is poorer for young women after mastectomy than BCS
SAN ANTONIO – A cohort study of 560 breast cancer survivors aged 40 or younger at diagnosis finds that breast satisfaction and several domains of...